GIP
UTHR icon

Granite Investment Partners’s United Therapeutics UTHR Stock Holding History

Granite Investment Partners’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-18,969
Closed -$4.17M – 279
2023
Q4 		$4.17M Buy
18,969
+176
+0.9% +$40.6K 0.16% 164
2023
Q3 		$4.24M Sell
18,793
-1,102
-6% -$254K 0.18% 148
2023
Q2 		$4.39M Buy
19,895
+1,299
+7% +$288K 0.17% 154
2023
Q1 		$4.16M Sell
18,596
-10,083
-35% -$2.49M 0.17% 146
2022
Q4 		$7.98M Sell
28,679
-128
-0.4% -$32.3K 0.33% 93
2022
Q3 		$6.03M Buy
28,807
+168
+0.6% +$37.6K 0.26% 111
2022
Q2 		$6.75M Buy
28,639
+1,601
+6% +$325K 0.28% 109
2022
Q1 		$4.85M Buy
27,038
+9,889
+58% +$1.88M 0.16% 151
2021
Q4 		$3.71M Buy
17,149
+1,861
+12% +$365K 0.11% 170
2021
Q3 		$2.82M Buy
+15,288
New +$3.01M 0.09% 187

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Granite Investment Partners's UTHR Position: Q1 2024 in Review

Granite Investment Partners sold out of United Therapeutics (UTHR) in Q1 2024, closing a stake of 18,969 shares — an estimated $4.17M sold.

Granite Investment Partners first reported a position in UTHR in Q3 2021 and held it in 10 quarters. The position peaked at $7.98M in Q4 2022. 526 funds tracked by Wall St. Rank hold UTHR as of Q1 2024.

  • Granite Investment Partners reported no remaining United Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Granite Investment Partners sold 18,969 United Therapeutics shares in Q1 2024, an estimated $4.17M.
  • Granite Investment Partners first reported a position in United Therapeutics in Q3 2021 and held it in 10 quarters.
  • Granite Investment Partners's United Therapeutics position peaked at $7.98M in Q4 2022.
  • 526 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2024.

Based on Granite Investment Partners's 13F filing for Q1 2024, filed 13 May 2024.